Did the study discuss the generality of the results to other settings and patientor client groups?.
If a sensitivity analysis was employed, was justification provided for the range of values (or for key study parameters)?
9.3. Were the study results sensitive to changes in the values (within the assumed range for sensitivity analysis, or within the confidence interval around the ratio of costs to consequences)? 10. Did the presentation and discussion of study results include all issues of concern to users?
10.1. Were the conclusions of the analysis based on some overall index or ratio of costs to consequences (e.g. cost-effectiveness ratio)? If so, was the index interpreted intelligently or in a mechanistic fashion?
10.2. Were the results compared with those of others who have investigated the same question? If so, were allowances made for potential differences in study methodology?
10.3. Did the study discuss the generality of the results to other settings and patient/client groups?
10.4. Did the study allude to, or take account of, other important factors in the choice or decision under consideration (e.g. distribution of costs and consequences, or relevant ethical issues)?
10.5. Did the study discuss issues of implementation, such as the feasibility of adopting the ‘preferred programme given existing financial or other constraints, and whether any freed resources could be redeployed to other worthwhile programmes?
(1) Drummond M et al. Methods for the Economic Evaluation of Health Care Programmes. 2nd ed. Oxford. Oxford University Press. 1997.
Did the study discuss the generality of the results to other settings and patientor client groups?
